VERVE THERAPEUTICS INC's ticker is VERV and the CUSIP is 92539P101. A total of 69 filers reported holding VERVE THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,641,000 | -29.3% | 350,000 | 0.0% | 0.27% | -26.4% |
| Q2 2023 | $6,562,500 | +129927.7% | 350,000 | 0.0% | 0.37% | +10.8% |
| Q1 2023 | $5,047 | -25.5% | 350,000 | 0.0% | 0.33% | -26.7% |
| Q4 2022 | $6,773 | -100.0% | 350,000 | -41.7% | 0.45% | -68.6% |
| Q3 2022 | $20,610,000 | +92.5% | 600,000 | -14.4% | 1.44% | +77.9% |
| Q2 2022 | $10,707,000 | -33.0% | 700,710 | 0.0% | 0.81% | -34.0% |
| Q1 2022 | $15,990,000 | -60.9% | 700,710 | -36.8% | 1.23% | -49.5% |
| Q4 2021 | $40,897,000 | +25.2% | 1,109,224 | +56.4% | 2.43% | +83.3% |
| Q3 2021 | $32,667,000 | -19.5% | 709,224 | 0.0% | 1.33% | -3.8% |
| Q2 2021 | $40,594,000 | – | 709,224 | – | 1.38% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARCH Venture Management, LLC | 2,008,809 | $26,636,807 | 17.30% |
| Alphabet Inc. | 10,549,086 | $139,880,880 | 8.98% |
| Casdin Capital, LLC | 2,954,710 | $39,179,455 | 4.34% |
| MPM BioImpact LLC | 857,940 | $11,376,284 | 3.04% |
| Saltoro Capital, LP | 66,500 | $881,790 | 0.79% |
| ARK Investment Management | 5,200,567 | $68,959,525 | 0.53% |
| Redmile Group, LLC | 809,777 | $10,737,643 | 0.51% |
| Ikarian Capital, LLC | 2,413 | $3,199,638 | 0.38% |
| Logos Global Management LP | 215,000 | $2,850,900 | 0.38% |
| Nikko Asset Management Americas, Inc. | 2,147,243 | $28,429,497 | 0.34% |